InvestorsHub Logo

HMB2010

03/17/21 1:48 PM

#303708 RE: Jimbo50 #303707

Seems some being touted so pre-maturely reeks of "pumping for quick flip" and how desperate investors (and patients/families) are for a glimpse of any hope toward AD treatment due to none presently.
Anavex sp should run exponentially with proven results like no pharma in history, imo.

boi568

03/17/21 1:49 PM

#303709 RE: Jimbo50 #303707

My take is that the market at any given moment is not all-knowing and rational. This provides investors with longer term opportunities.

Foosfund

03/17/21 1:58 PM

#303712 RE: Jimbo50 #303707

Jimbo, SAVA is valued at $2.3 billion vs.AVXL $930 million. About a year ago +/- AVXL and SAVA had about equal evaluation..